Core C TEST IT

核心 C 测试

基本信息

项目摘要

The skin forms a primary interface with the environment, with the keratinocyte a critical component of the innate immune system. Perturbation of healthy skin can lead to inflammation through cutaneous immune responses. As such, the immunology of skin is an important focus of a SBDRC with “The Keratinocyte and its Microenvironment” as its theme. he skin immune system entails an interactive set of innate and adaptive immune cells that can be studied in situ, taken apart for studies at the single cell level, or reconstructed to recreate immune conditions of the skin. The objective of the Translational and Experimental Skin Testing and Immune Tracing (TEST IT) Core is to support and promote the research of SBDRC scientists interested in human and murine cutaneous immune responses in health and disease. The Core will isolate various immune cells from healthy and diseased skin, including at the single cell level, and offer preparative services for the characterization of these cells directly or in functional assays. Using Vectra multispectral imaging equipment, the Core will assist in designing experiments allowing in situ monitoring of human and mouse skin samples, explants and engineered skin. The Core will provide guidance for the efficient expansion of immune cells from skin and blood to be recombined with 3D reconstituted human skin or explants by the Skin Tissue Engineering and Morphology (STEM Core). Prior to reconstruction, cells can be genetically manipulated with products from the Gene Engineering, Transduction and Nanotechnology (GET iN) Core. These engineered keratinocyte-immune cell models will then be available for further immune assessment. A unique and highly novel aspect of the TEST IT core will be to provide a skin challenge facility for in vivo monitoring. This will be accomplished through a dedicated clinical unit and staff to test exposure to environmental agents that affect skin immunologically, whether in a potentially deleterious way, such as ultraviolet/UV light, or in a beneficial way, such as topical medications that suppress immune responses. The Core will oversee the Tissue Acquisition Program (TAP), which obtains archival samples, as well as fresh skin, blood, and other samples (including through the in vivo skin challenge facility) for a central biorepository with secure records; coded, deidentified tissues are distributed to scientists for use in individual laboratories or the service Cores. The Core will also maintain a roster of healthy volunteers and individuals with skin disease who are willing to participate in IRB-approved, skin challenge experiments. These translational studies support mechanistic investigations and provide proof-of-concept data. The Core also focuses on training the research community about immunodermatology, offering expertise in designing mouse and human experiments involving the skin immune system and generating course material in immunodermatology, immunotherapeutics, and immune monitoring. This is a novel core that focuses on enabling investigators to perform advanced and highly translational immune skin research. The ability to study perturbed human skin in a controlled manner will greatly facilitate translational research.
皮肤与环境形成主要界面,角膜细胞是先天的关键组成部分 免疫系统。健康皮肤的扰动会通过皮肤免疫反应导致炎症。 因此,皮肤的免疫学是SBDRC的重要重点 微环境作为主题。他的皮肤免疫系统需要一组互动的先天和适应性免疫 可以原位研究的细胞,在单细胞水平上进行研究或重建以重建 皮肤的免疫条件。翻译和实验性皮肤测试和免疫的目的 跟踪(测试)核心是支持和促进对人类和人类感兴趣的SBDRC科学家的研究 鼠健康和疾病中的鼠皮肤免疫反应。核心将使各种免疫细胞与 健康且厌恶的皮肤,包括在单细胞水平上,并为表征提供准备的服务 这些细胞直接或在功能测定中。使用Vectra多光谱成像设备,核心将有助于 在设计实验时,可以原位监测人和老鼠皮肤样品,外植体和设计 皮肤。核心将为皮肤和血液中免疫细胞有效扩张提供指导 通过皮肤组织工程和形态与3D重建的人皮或外植体重新融合 (茎芯)。在重建之前,可以用基因的产物对细胞进行遗传操纵 工程,转导和纳米技术(进入)核心。这些设计的角质形成细胞 - 免疫细胞 然后,模型将用于进一步的免疫评估。测试的独特且新颖的方面 核心将为体内监测提供皮肤挑战设施。这将通过 专门的临床部门和工作人员测试暴露于影响皮肤免疫学上的环境药物, 无论是以潜在删除的方式,例如紫外线/紫外线,还是以有益的方式,例如局部 抑制免疫反应的药物。核心将监督组织采集计划(TAP), 获得档案样品以及新鲜的皮肤,血液和其他样品(包括通过体内) 皮肤挑战设施)用于具有安全记录的中央生物座席;编码,去识别的组织分布 向科学家用于单个实验室或服务核心。核心还将保持健康阵容 愿意参加IRB批准的皮肤挑战的志愿者和皮肤病的人 实验。这些翻译研究支持机械投资并提供概念证明数据。 该核心还专注于培训研究界有关免疫皮肤病学的知识,并提供专业知识 设计涉及皮肤免疫系统并生成课程材料的鼠标和人类实验 免疫皮肤病学,免疫治疗和免疫监测。这是一个新颖的核心,着重于实现 研究人员进行高级和高度翻译的免疫皮肤研究。学习扰动的能力 人类皮肤以受控的方式将极大地促进转化研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

I. Caroline Le Poo...的其他基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Core C TEST IT
核心 C 测试
  • 批准号:
    10455749
    10455749
  • 财政年份:
    2019
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Core C TEST IT
核心 C 测试
  • 批准号:
    10700043
    10700043
  • 财政年份:
    2019
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Separating autoimmunity and anti-tumor immunity
区分自身免疫和抗肿瘤免疫
  • 批准号:
    9539082
    9539082
  • 财政年份:
    2015
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Separating autoimmunity and anti-tumor immunity
区分自身免疫和抗肿瘤免疫
  • 批准号:
    8990922
    8990922
  • 财政年份:
    2015
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo
调节自发性小鼠自身免疫性白癜风模型的耐受性
  • 批准号:
    8457139
    8457139
  • 财政年份:
    2010
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo
调节自发性小鼠自身免疫性白癜风模型的耐受性
  • 批准号:
    8655790
    8655790
  • 财政年份:
    2010
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo
调节自发性小鼠自身免疫性白癜风模型的耐受性
  • 批准号:
    8064251
    8064251
  • 财政年份:
    2010
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo
调节自发性小鼠自身免疫性白癜风模型的耐受性
  • 批准号:
    8134274
    8134274
  • 财政年份:
    2010
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo
调节自发性小鼠自身免疫性白癜风模型的耐受性
  • 批准号:
    8271256
    8271256
  • 财政年份:
    2010
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:

相似国自然基金

YTHDF3调控CXCL13表达影响黑色素瘤免疫微环境及PD-1抗体疗效的机制
  • 批准号:
    82303866
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
AID介导抗体重链非编码区重组调控质膜BCR密度并影响记忆B细胞命运决定的研究
  • 批准号:
    32370948
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
  • 批准号:
    82360402
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
  • 批准号:
    82304205
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
心衰患者中单克隆β1-肾上腺素受体自身抗体的筛选及其对受体构象影响的研究
  • 批准号:
    32271156
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目

相似海外基金

Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
  • 批准号:
    10555899
    10555899
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Bioorthogonal probe development for highly parallel in vivo imaging
用于高度并行体内成像的生物正交探针开发
  • 批准号:
    10596786
    10596786
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Defining the role of ligand spatial organization in T cell signaling with DNA origami
用 DNA 折纸定义配体空间组织在 T 细胞信号传导中的作用
  • 批准号:
    10680089
    10680089
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Identifying the mechanistic role of and reversing aberrant neural activity in Alzheimer's Disease
识别阿尔茨海默病中异常神经活动的机制作用并逆转
  • 批准号:
    10740789
    10740789
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别:
Prohibiting Cell Death in Human Keratocytes: New Insights for Non-surgical Keratoconus Treatment
抑制人角膜细胞的细胞死亡:非手术圆锥角膜治疗的新见解
  • 批准号:
    10720431
    10720431
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
    $ 18.54万
  • 项目类别: